Original Article Biomol Ther 275 450456 2019 Anxiolytic Action Taurine Intranasal Administration Mice Jung Hwa Jung SungJin Kim Department Pharmacology Toxicology Metabolic Diseases Research Laboratory School Dentistry Kyung Hee University Seoul 02447 Republic Korea Abstract Taurine number beneficial pharmacological actions brain anxiolytic neuroprotective actions We ex plored test taurine transported central nervous intranasal route Following intranasal administration taurine mice elevated plus maze test activity cage test rota rod test carried verify taurines effect anxiety For characterization potential mechanism taurines antianxiety action mouse convulsion tests strychnine picrotoxin yohimbine isoniazid employed A significant increase time spent open arms observed taurine administered nasal route elevated plus maze test In addition vertical horizontal activities mice treated taurine intranasal route considerably diminished These results support hypothesis taurine transported brain intranasal route inducing antianxiety activity Taurines antianxiety action mediated strychninesensitive glycine receptor evidenced inhibition strychnineinduced convulsion Key Words Antianxiety Taurine Elevated plus maze test Activity cage test Strychnine Glycine receptor INTRODUCTION Taurine 2aminoethane sulfonic acid classified βamino acid It unique structural features presence sulfonic group βform configuration Zhang Kim 2007 Though taurine present body supply diet necessary relatively low activity enzyme cysteinsulfinic acid decarboxylase major regulator taurine biosynthesis Taurine biosynthesized cyste ine methionine liver synthesized taurine transported organs taurine transporter Huxtable Barbeau 1976 Huxtable 1986 Strikingly taurine present brain large exerts important neuronal functions ticonvulsant regulation neuronal excitability learning memory formation antiaggressiveness enhancing CNS velopment antialcoholic effect Huxtable 1992 There interesting proposal taurine deriva tive glutaurine work neurotransmitter neuromod ulator Furthermore taurine plays important roles regulating structural stability cell membrane depolariza tionassociated calcium channel activity Kuriyama 1980 Lin et al 1983 Moran et al 1988 Sturman 1993 Open Access httpsdoiorg104062biomolther2018218 This Open Access article distributed terms Creative Com mons Attribution NonCommercial License httpcreativecommonsorglicens esbync40 permits unrestricted noncommercial use distribution reproduction medium provided original work properly cited The physiological importance taurine sup ported study taurine deficiency generation epi lepsy associated taurine deficiency Birdsall 1998 Taurine potential anxiolytic effects animal models Chen et al 2004 Kong et al 2006 ze brafish models Rosemberg et al 2012 Fontana et al 2016 2019 Mezzomoa et al 2016 exact mechanism action remains fully characterized Benzodiazepines long treatment anxiety unwanted effects reported memory impairment addiction problem muscle relaxation Thus necessary develop new drugs fewer effects safety patients Considering taurine agonist strychninesensitive glycine receptors present rat striatum Sergeeva Haas 2001 good possibility taurine teract glycine receptor vivo However use taurine brain extremely difficult poor pen etration rate brain taurine strong hydrophilicity sulfonic acid instead carboxylic acid makes hard penetrate blood brain barrier Chung et al 2012 Recently intranasal administration methods alternative route efficient delivery bioac tive molecules brain Numerous studies Received Nov 8 2018 Revised Jan 20 2019 Accepted Feb 20 2019 Published Online Mar 25 2019 Corresponding Author Email kimsjkhuackr Tel 8229610868 Copyright 2019 The Korean Society Applied Pharmacology wwwbiomoltherorg 450 B e h t n t n e p s e m t l t o T A s e r t n e s m r l t o T 120 110 90 80 70 60 50 40 30 20 10 0 m gkg C ontrol T 200 n m s m r 45 40 35 30 25 20 15 10 05 00 m gkg C ontrol T 200 D s 40 m r n e p o n t n e p s e m T 30 20 10 0 C s m r n e p o n s e r t n E 60 50 40 30 20 10 0 m gkg C ontrol T 200 E s m r n e p o n t n e p s e m T m gkg C ontrol T 200 n m 15 10 05 00 F s m r d e s o c n l t n e p s e m T m gkg C ontrol T 200 n m 4 3 2 1 0 m gkg C ontrol T 200 Fig 1 Effect taurine anxiety elevated plus maze test mice Following taurine administration 200 mgkg IN elevated plus maze test performed described Materials Methods Data expressed mean SEM p005 p001 p0001 compared control group n8 reported dealing delivery neuropeptides pro teins brain nasal route Kamei TakedaMorishi ta 2015 Intranasal delivery peptides employed treatment neurodegenerative diseases Meredith et al 2015 It allow taurine bypass blood brain barrier taurine enter CNS routes trigeminal nerve intercellular cleft olfactory epithelium Kozlovskaya et al 2014 Lochhead Thorne 2015 In present study possibility nasal delivery tau rine CNS tested We presented evidence taurine delivered brain causing antianx iety action MATERIALS AND METHODS Animals Male ICR mice purchased Hanlim Experimental Animals Co Hwaseong Korea Male ICR 2530 g 6 weeks old mice caged temperature 22 2C venti lationcontrolled room 12h lightdark cycle A standard pellet diet tap water supplied ad libitum Through experiments animals processed according Animal Care Use Guidelines issued Kyung Hee University Seoul Korea All experiment protocols ap proved Institutional Animal Care Use Committee Kyung Hee University KHUASPSE15114 After week acclimation period animals experiment Strychnine picrotoxin yohimbine isoniazid pur chased Tocris Minneapolis MN USA Intranasal taurine delivery mice Intranasal IN delivery taurine carried es sentially described Marks et al 2009 Briefly mice handrestrained placed supine position given 10 microliter drops 80 μgμl taurine saline 09 nares 200 mg taurine body weight micropipette Pipetman P20 Gilson Inc Middleton WI USA Mice given extra microliter treatment drop subject forcibly ejected sneezed solution Mice held supine 510 s delivery sure taurine containing solution inhaled Elevated plus maze test The plus maze consisting open arms 605 cm enclosed arms 60520 cm elevated height 60 cm described earlier Pellow et al 1985 Mice treated saline taurine 200 mgkg IN 60 min later placed individually center plus maze facing enclosed arm The time spent enclosed open arms number entries enclosed open arms 5min test period recorded Activity Cage test Groups 10 mice weight 35 40 g They treated intranasally saline taurine 200 mgkg IN 1 h later mice tested spontane ous locomotor activity associated anxiety 4 min use Activity Cage purchased Ugo Basile Gemonio Italy Amos et al 2004 Votava et al 2005 Briefly following treatment taurine saline mice evaluated horizontal vertical activities 4 min according providers instruction manual Rota rod test Each mouse trained run Rota rod 3 cm diam eter 15 rpm remain 300 s fall ing The mice evaluated Rota rod performance test 300 s 60 min distilled water taurine 200 mg IN treatment Tsuda et al 1996 Passive avoidance test The test basically performed according step method described earlier Park et al 2000 The Gemini Avoidance System SD Instruments San Diego CA USA experiment The apparatus consisted twocompartment acrylic box lightened compart ment connected darkened automatic guillotine door Mice placed lighted box 300 s guillotine door opened The mice soon en tered dark compartment received punishing electrical shock 03 mA 1 s The latency times entering dark compartment measured training test 24 h retention test The maximum entry latency allowed retention session 180s Mohamed et al 2000 Taurine 200 mgkg IN distilled water administered 60 min prior training session passive avoidance test 451 wwwbiomoltherorg Jung Kim Intranasal Delivery Taurine Biomol Ther 275 450456 2019 s p e t s l t n o z r o h f o r e b m u N 700 600 500 400 300 200 100 0 s p e t s l c t r e v f o r e b m u N 70 60 50 40 30 20 10 0 n m d o r t o r n o t n e p s e m T 5 4 3 2 1 0 Control T 200 mgkg Control T 200 mgkg Control T 200 mgkg Fig 2 Effect taurine spontaneous locomotor activity activity cage test mice Following taurine administration 200 mgkg IN activity cage test performed described Materials Methods Data expressed mean SEM p001 p0001 compared control group n8 Fig 3 Effect taurine muscle relaxation Rota rod test mice Following taurine administration 200 mgkg IN Rota rod test carried described Materials Meth ods The time spent Rota rod measured Data ex pressed mean SEM n8 StrychnineInduced convulsions Groups 10 mice weight 35 40 g They treated intranasal distilled water tau rine 200 mgkg IN 1 h later mice injected 2 mgkg strychnine ip The time occurrence tonic ex tensor convulsion death noted 1h period Bigler 1977 PicrotoxinInduced convulsions Groups 10 mice weight 35 40 g They treated intranasal distilled water tau rine 200 mgkg IN 1 h later mice injected 35 mgkg picrotoxin sc The time occurrence clonic sei zure noted 30min period Usunoff et al 1969 taurine There significant difference terms total arms entries Fig 1A total time spent arms Fig 1B control taurine groups Administration taurine 200 mgkg IN caused sig nificant increase percent open arm entries open arm total100 control taurine 200 mgkg 287 457 respectively Fig 1C Percent time spent open arms significantly increased taurine treatment 200 mgkg IN control taurine 200 mgkg 126 336 respectively Fig 1D The actual time spent open arms control group taurine treated group 049 min 116 min respectively Fig 1E The actual number entries open arms control group taurine treated group 343 min 227 min respectively Fig 1F YohimbineInduced convulsions Activity cage test Groups 10 mice weight 35 40 g They treated intranasal distilled water tau rine 200 mgkg IN 1 h later mice injected 45 mgkg yohimbine sc The time occurrence clonic sei zure 60min period recorded Dunn Fielding 1987 IsoniazidInduced convulsions Groups 10 mice weight 35 40 g They treated intranasal distilled water tau rine 200 mgkg IN 1 h later mice injected 45 mgkg isoniazid sc The time occurrence clonic tonic seizures time death recorded 2h period Meredith et al 2015 Activity cage tests widely accepted ex perimental tool test antianxiety actions drugs Following taurine administration 200 mgkg IN mice delivered activity cage 4 min evaluated horizontal vertical activities Taurine treatment caused decrease horizontal steps 43 diminished vertical steps 81 compared controls Fig 2 Rota rod test To explore potential effect taurine muscle laxation rota rod test performed Taurine administration 200 mgkg IN cause significant changes rota rod test suggesting little effect muscle relaxation Fig 3 Statistical analysis Passive avoidance test Each value expressed mean standard error mean SEM multiple determinations All statistical analyses Prism 50 software GraphPad Software San Diego CA USA Analysis nonparametric unpaired ttest The differences considered statistically significant p005 RESULTS Elevated plus maze test Elevated plus maze test employed explore po tential antianxiety actions intra nasally IN administered To evaluate taurines potential effect memory forma tion passive avoidance test carried Taurine adminis tration intra nasal route 200 mgkg IN change retention times training test session suggesting little direct effect memory function Fig 4 Convulsions test Taurine dose 200 mgkg increased latency onset clonic seizure caused strychnine 40 compared control Fig 5 Taurine prolonged induc tion time death 20 compared control Fig 5 However taurine little effect latency onset convulsion caused picrotoxin Fig 6 yohimbine Fig httpsdoiorg104062biomolther2018218 452 k r d e h t r e t n e o t y c n e t L s t n e m t r p m o c t s e t g n n r t 30 20 10 0 k r d e h t r e t n e o t y c n e t L s t n e m t r p m o c t s e t n o t n e t e r 300 200 100 0 s e r u z e s c n o t y c n e t L n m 5 4 3 2 1 0 n m h t e d f o e m T 5 4 3 2 1 0 Control T 200 mgkg Control T 200 mgkg Control T 200 mgkg Control T 200 mgkg Fig 4 Effect taurine cognition passive avoidance test mice Following taurine administration 200 mgkg IN passive avoidance test performed described Materials Methods Latency enter dark compartment measured training test retention Data expressed mean SEM n8 Fig 5 Effect taurine strychnineinduced convulsion mice Following taurine administration 200 mgkg IN convulsion induced strychnine described Materials Meth ods Latency convulsion time death measured Data expressed mean SEM p001 compared control group n8 7 Taurine little effect latency clonic tonic seizures time death caused isoniazid Fig 8 DISCUSSION Taurine derivative cysteine exerts wide variety pharmacological actions body including CNS effects neuroprotection antianxiety Taurine extensively studied investigators peripheral tis sues actions CNS fully stood As alternative route taurine administration possibility nasal delivery taurine brain tested We present evidence taurine readily transported brain intranasal delivery causing anxiolytic effects Taurine 2aminoethane sulfonic acid important ami acid derivative playing essential physiological roles body bile acid conjugation osmoregulation cardio vascular regulation antioxidation Interestingly taurine transported brain induce number CNS actions including antianxiety effect However poor transport brain limited clinical application We previously taurine administration PER ORAL induce significant antianxiety effect activation strychninesensitive glycine receptor Zhang Kim 2007 prompted investigate pos sibility intranasal delivery taurine antianxiety ac tion The anxiolytic action taurine intranasal delivery evidenced activity cage test elevated plus maze test It suggested decrease horizontal vertical activity agent correlated anx iolytic action Amos et al 2005 Spontaneous locomotor activity measured activity cage test regarded index level excitability CNS Mansur et al 1971 Drug causes decrease spontaneous locomotor activity anxiolytic Ozturk et al 1996 In activity cage test taurine administration intranasal route caused remarkable reduction horizontal vertical activities suggesting taurines antianxiety action The activation strychninesensitive glycine receptor tau rine cause hyperpolarization neuronal membrane receptorassociated chloride channels lead anxiolytic action Elevated plus maze test commonly accepted tool evaluation antianxiety action Pellow et al 1985 It documented anxiolytic molecules increase time spent open arm elevated plus maze test Taurines antianxiety action intranasal delivery clearly evident elevated plus maze test time spent open arm significantly increased Taurine administration intrana sal delivery little effect muscle relaxation shown Rota rod test This feature taurine beneficial compared conventional anxiolytic drug benzo diazepine muscle relaxation activity To explore mechanism taurines antianxiety action caused intranasal delivery convulsions induced strych picrotoxin yohimbine isoniazid tested The doses strychnine picrotoxin yohimbine isoniazid em ployed convulsion tests widely study anxiolytic effects compounds Costa et al 1975a 1975b Dunn Fielding 1987 GABAA receptor ligandgated chloride channel multiple binding sites picrotoxin yohimbine GABA Leite Cascio 2001 Anionselective transmittergated ion channels cys loop super family contain GABAA receptors strychnine sensitive glycine receptors Yevenes Zeilhofer 2011 The binding GABA GABAA receptor causes conformational change receptor complex resulting hyperpolar ization neuronal cells opening chloride channel By contrast binding picrotoxin yohimbine GABAA ceptor complex blocks opening chloride channel caus ing convulsion Thus present results intranasal ad ministration taurine little effect picrotoxin yohimbineinduced convulsion clearly suggest taurines antianxiety action mediated GABAA receptor Since possibility taurine affect synthesis GABA isoniazid employed Isoniazid drug treatment tuberculosis known hibit GABA synthesis inducing convulsion Costa 1975b When taurine administered intranasal route pretreatment isoniazid convulsions induced iso niazid affected These results indicate taurine little effect GABA synthesis process Glycine receptor ligandgated chloride channel differ 453 wwwbiomoltherorg Jung Kim Intranasal Delivery Taurine Biomol Ther 275 450456 2019 s e r u z e s c n o c l y c n e t L n m 15 10 5 0 Control T 200 mgkg Fig 6 Effect taurine picrotoxininduced convulsion mice Following taurine administration 200 mgkg IN convulsion induced picrotoxin described Materials Meth ods Latency convulsion measured Data expressed mean SEM n8 s e r u z e s c n o c l y c n e t L n m 35 30 25 20 15 10 5 0 Control T 200 mgkg Fig 7 Effect taurine yohimbineinduced convulsion mice Following taurine administration 200 mgkg IN convulsion induced yohimbine described Materials Meth ods Latency convulsion measured Data expressed mean SEM n8 ent structure compared GABAA receptor Activation glycine receptor binding glycine induces confor mational change receptor subsequently opens associated chloride channel causing sedation Graham et al 1982 Strychninesensitive glycine receptors pentameric anion channel consisting α1α4 β Lynch 2004 specific binding site strychnine When strychnine binds glycine receptor inactivated associ ated chloride channel closed eventually leading convulsion The strychninesensitive glycine receptors ex pressed brain regions hippocampus brain stem spinal cord cerebellum retina Legendre et al 2009 Yevenes Zeilhofer 2011 They playing impor tant role regulating respiratory rhythm muscle tone pain sensory transmission convulsion Harvey et al 2004 Re inold et al 2005 Eichler et al 2008 Manzke et al 2010 A recent report suggested potential role strychnine sensitive glycine receptor Komatsu et al 2015 control anxiety In present study intranasal taurine delivery increased time induce convulsion caused strychnine suggesting taurine exert antianxiety action activation strychninesensitive glycine receptors Recently intranasal delivery peptide protein draws attention provides alternative route CNS drug delivery Meredith et al 2015 Intranasal peptides proteins directly diffuse brain intercel lular cleft olfactory epithelium trigeminal nerve Kozlovskaya et al 2014 Lochhead httpsdoiorg104062biomolther2018218 454 A B C n m s e r u z e s c n o c l y c n e t L 40 30 20 10 0 m gkg C ontrol T 200 n m s e r u z e s c n o t y c n e t L 50 40 30 20 10 0 m gkg C ontrol T 200 n m h t e d f o e m T 50 40 30 20 10 0 m gkg C ontrol T 200 Fig 8 Effect taurine isoniazidinduced convulsion mice Following taurine administration 200 mgkg IN convulsion induced isoniazid described Materials Meth ods Latency A clonic B tonic seizures C time death measured Data expressed mean SEM n8 Thorne 2015 Interestingly direct pathway molecules transported brain lymphatic vasculature subsequently blood brain barrier We propose intranasally admin istered taurine transported brain direct pathways containing olfactory epithelium andor trigeminal nerve However rule possibility intra nasally administered taurine enter brain lymphatic vasculature subsequently pass blood brain barrier exerting antianxiety action Since strychnine sensitive glycine receptors expressed hippocampus brain stem spinal cord cerebellum retina Legendre et al 2009 Yevenes Zeilhofer 2011 taurine transported intranasal pathway interact strychninesensi tive glycine receptors aforementioned brain regions inducing CNS actions including anxiolytic activity It strychninesensitive glycine receptors expressed adult rat amygdala McCool Bot ting 2000 taurine activate receptors McCool Chappell 2007 finding suggests intranasally delivered taurine interact strychninesensitive glycine receptor regulate anxiety amygdala plays important role regulation emotion It possible taurineinduced anxiolytic behavior mediated dopa regulation considering taurine elevates dopamine levels nucleus accumbens Ericson et al 2006 Taken clearly demonstrated taurine delivered brain intranasal route inducing antianxiety action These results suggest intranasal administration alternative route delivery taurine brain induce antianxiety action Intranasal delivery taurine considered clinical situations requiring anxiety control In conclusion taurine ex erts significant antianxiety action intranasal delivery possibly binding activating strychninesen sitive glycine receptor vivo Future studies necessary compare efficacy intranasal administration taurine administration routes REFERENCES Amos S Akah P A Enwerem N Chindo B A Hussaini I M Wambebe C Gamaniel K K 2004 Behavioural effect Pavetta cassipes extract rodents Pharmacol Biochem Behav 77 751759 Amos S Abbah J Chindo B Edmond I Binda L Adzu B Bu hari S Odutola A A Wambebe C Gamaniel K 2005 Neuropharmacological effects aqueous extract Nauclea latifolia root bark rats mice J Ethnopharmacol 97 5357 Bigler E D 1977 Comparison effects bicuculline strychnine picrotoxin pentylenetetrazol photically evoked afterdischarges Epilepsia 18 465470 Birdsall T C 1998 Therapeutic application taurine Altern Med Rev 3 128136 Chen S W Kong W X Zhang Y J Li Y L Mi X J Mu X S 2004 Possible anxiolytic effects taurine mouse elevated plus maze Life Sci 75 15031511 Chung M C Malatesta P Bosquesi P L Yamasaki P R dos San tos J L Vizioli E O 2012 advances drug design based amino acid approach taurine analogues treatment CNS diseases Pharmaceuticals 5 11281146 Costa E Guidotti A Mao C C 1975a New concepts mechanism action benzodiazepines Life Sci 17 167186 Costa E Guidotti A Mao C C 1975b Evidence involve ment GABA action benzodiazepines studies rat cer ebellum Adv Biochem Psychopharmacol 14 113130 Dunn R Fielding S 1987 Yohimbineinduced seizures mice A model predictive potential anxiolytic GABAmimetic agents Drug Dev Res 10 177188 Eichler S A Kirischuk S Juttner R Schafermeier P K Legendre P Lehman T N Gloveli T Grantyn R Meier J C 2008 Glycinergic tonic inhibition hippocampal neurons depolar izing GABAergic transmission elicits histopathological signs tem poral lobe epilepsy J Cell Mol Med 12 28482866 Ericson M Molander A Stomberg R Söderpalm B 2006 Taurine elevates dopamine levels rat nucleus accumbens antagonism strychnine Eur J Neurosci 23 32253229 Fontana B D Meinerz D L Rosa L V C Mezzomo N J Silveira A 2016 Modulatory action taurine ethanolinduced aggressive behavior zebrafish Pharmacol Biochem Behav 141 1827 Fontana B D Ziani P R Canzian J Mezzomo N J Müller T E dos Santos M M Loro V L Barbosa N V Mello C F Rosemberg D B 2019 Taurine protects pentylenetetrazole induced behavioral neurochemical changes zebrafish Mol Neurobiol 56 583594 Graham D Pfeiffer F Betz H 1982 Avermectin B1a inhibits binding strychnine glycine receptor rat spinal cord Neurosci Lett 29 173176 Harvey R J Depner U B Wassle H Ahmadi S Heindl C Re inold H Smart T G Harvey K Schütz B AboSalem O M Zimmer A Poisbeau P Welzl H Wolfer D P Betz H Zeil hofer H U Müller U 2004 GlyR α3 essential target spinal PGE2mediated inflammatory pain sensitization Science 304 884887 Huxtable R J 1986 The Biochemistry Sulfur Plenum Press New York Huxtable R J Barbeau A 1976 Taurine Raven Press New York Huxtable R 1992 Physiological actions taurine Physiol Rev 72 101163 Kamei N TakedaMorishita M 2015 Brain delivery insulin boosted intranasal coadministration cellpenetrating pep tides J Control Release 197105110 Komatsu H Furuya Y Sawada K Asada T 2015 Involve ment strychninesensitive glycine receptor anxiolytic effects GlyT1 inhibitors maternal separationinduced ultra sonic vocalization rat pups Eur J Pharmacol 746 252257 Kong W X Chen S W Li Y L Zhang Y J Wang R Min L Mi X 2006 Effects taurine rat behaviors anxiety models Pharmacol Biochem Behav 83 271276 Kozlovskaya L AbouKaoud M Stepensky D 2014 Quantita tive analysis drug delivery brain nasal route J Control Release 189 133140 Kuriyama K 1980 Taurine neuromodulator Fed Proc 39 26802684 Legendre P Forstera B Juttner R Meier J C 2009 Glycine receptors caught genome proteome functional im plications RNA editing splicing Front Mol Neurosci 2 23 Leite J Cascio M 2001 Structure ligandgated ion channels critical assessment biochemical data supports novel topology Mol Cell Neurosci 17 777792 Lin C T Su Y Y T Song G X Wu J Y 1983 Is taurine neurotransmitter rabbit retina Brain Res 337 293298 Lochhead J J Thorne R G 2015 Intranasal delivery biolog ics central nervous Adv Drug Deliv Rev 64 614 628 Lynch J W 2004 Molecular structure function glycine receptor chloride channel Physiol Rev 84 10511095 Manzke T Niebert M Koch U R Caley A Vogelsesang S Huls mann S Ponimaskin E Müller U Smart T G Harvey R J Richter D W 2010 Serotonin receptor 1Amodulated phos phorylation glycine receptor α3 controls breathing mice J Clin Invest 120 41184128 McCool B A Botting S K 2000 Characterization strychnine sensitive glycine receptors acutely isolated adult rat basolateral amygdala neuron Brain Res 859 341351 McCool B A Chappell A 2007 Strychnine taurine modula tion amygdalaassociated anxietylike behavior state depen dent Brain Res 178 7081 Meredith M E Salameh T S Banks W A 2015 intranasal delivery proteins peptides treatment neurodegen erative diseases AAPS J 17 780787 Mezzomoa N J Silveira A Giuliania G S Quadrosa V A Rosemberga D B 2016 The role taurine anxietylike haviors zebrafish A comparative study novel tank lightdark tasks Neurosci Lett 613 1924 Mohamed A F Matsumoto K Tabata K Takayama H Kitajima M Aimi N Watamabe H 2000 Effects Uncaria tomen tosa total alkaloid components experimental amnesia mice elucidation passive avoidance test J Pharm Phar macol 52 15531561 Moran J Solazar P PasantesMorales H 1988 Effect copherol taurine membrane fluidity retinal rod outer seg ments Exp Eye Res 45 769776 Mansur J Martz R M W Carlini E A 1971 Effects acute chronic administration Cannabis sativa 9trans tetra hedron cannabinol behaviour rats open field arena Psychopharmacology 19 338397 Marks D R Tucker K Cavallin M A Mast T G Fadool D A 2009 Awake intranasal insulin delivery modifies protein com plexes alters memory anxiety olfactory behaviors J Neurosci 29 67346751 Ozturk Y Aydine S Ben R Baser K H C Berberoglu H 1996 Behavioural effects Hypericum perforatum L Hyperi cum calycinum L extracts central nervous systems mice Phytomedicine 3 139146 Park C R Seeley R J Craft S Wood S C 2000 Intracere broventricular insulin enhances memory passiveavoidance task Physiol Behav 68 509514 Pellow S Chopin P H File S E Briley M 1985 Validation openclosed arm entries elevated plusmaze measure anxiety rat J Neurosci Methods 14 149167 Reinold H Ahmadi S Depner U B Layh B Heindl C Hamza M Pahl A Brune K Narumiya S Müller U Zeilhofer H U 2005 Spinal inflammatory hyperalgesia mediated prosta glandin E receptors EP2 subtype J Clin Invest 115 673 679 Rosemberg D B Braga M M Rico E P Loss C M Córdova S D Mussulini B H M Blaser R E Leite C E Campos M M Dias R D Calcagnotto M E Oliveira D L Souza D O 2012 Behavioral effects taurine pretreatment zebraf ish acutely exposed ethanol Neuropharmacology 63 613623 455 wwwbiomoltherorg Jung Kim Intranasal Delivery Taurine Biomol Ther 275 450456 2019 Sergeeva O A Haas H L 2001 Expression function glycine receptor striatal cholinergic interneurons rat mouse Neuroscience 104 10431055 Sturman J A 1993 Taurine development J Physiol Rev 73 119147 Tsuda M Suzuki T Misawa M Nagase H 1996 Involvement opioid anxiolytic effect diazepam mice Eur J Pharmacol 307 714 Usunoff G Atsev E Tchavdarov D 1969 On mechanism picrotoxin epileptic seizure macro microelectrode investiga tions Electroencephalogr Clin Neurophysiol 27 444447 Votava M Hess L Slíva J Krsiak M Agová V 2005 Dexme detomidine selectively suppresses dominant behavior aggres sive sociable mice Eur J Pharmacol 523 7985 Yevenes G E Zeilhofer H U 2011 Allosteric modulation glycine receptors Br J Pharmacol 164 22436 Zhang C G Kim S J 2007 Taurine induces antianxiety activating strychninesensitive glycine receptor vivo Ann Nutr Metab 51 379386 httpsdoiorg104062biomolther2018218 456